Dr. Costica Aloman, MD

Dr. Aloman practices at Westchester Medical Center in Valhalla, New York, part of Westchester Medical Center Health Network.

Dr. Aloman's NPI, 1629277652, was assigned on July 11, 2007. Dr. Aloman graduated from Carol Davila University of Medicine and Pharmacy in 1995. Dr. Aloman holds New York license 245194.

Dr. Aloman's primary practice is Westchester Medical Center, at 100 Woods Rd, Valhalla, NY 10595 in Westchester County. The practice phone is (914) 493-7000.

Dr. Aloman's primary practice is Westchester Medical Center in Valhalla, New York, part of Westchester Medical Center Health Network. The medical group on file is Westchester Medical Center Advanced Physician Services. Dmand AI also links Dr. Aloman to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aloman practices. Vendor and product names are available with a free account.

Hepatology is Dr. Aloman's primary specialty in the NPI Registry, under taxonomy code 207RI0008X. Dr. Aloman is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Aloman's licenses on file in 5 states: New York, Illinois, Indiana, Rhode Island and Iowa.

Dmand AI lists cirrhosis of the liver, fatty liver and hepatitis c among the conditions Dr. Aloman treats.

CMS data shows 278 Medicare services from Dr. Aloman across 6 procedure codes in 2024, for 108 Medicare patients. Medicare paid $26,351 for them.

CMS counts 108 Medicare patients who saw Dr. Aloman in 2024. The largest group is 65 to 74, with 48 patients. 74% of them have high blood pressure, and 59% have high cholesterol. 37% are also on Medicaid. Their average risk score is 2.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aloman's median patient age at 58, with 49% women.

In 2024, Dr. Aloman wrote 444 Medicare Part D claims for 100 patients. 82% of them were for generic drugs. CMS names the drug for 287 of them, across 11 drugs with 11 or more claims each, at $139,802 in total drug cost. In 2023, CMS named 240 claims across 12 drugs.

Dr. Aloman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 53 papers to Dr. Aloman, published from 2008 to 2024. 2020 was the busiest year, with 12. The most frequent topics are Liver, Dendritic Cells and Disease Models, Animal. Dr. Aloman has published most often in Hepatology. Dr. Aloman's most frequent co-authors are Thomas D. Schiano, MD, Scott L. Friedman, MD and Renumathy Dhanasekaran, MD, PhD.

CMS Open Payments shows 39 general payments to Dr. Aloman from 14 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 60% of the total. Ipsen Biopharmaceuticals, Inc paid the most, $2,330.

Dmand AI lists 1 award for Dr. Aloman, most recently CMS Stage 1 EHR in 2012.

Dr. Aloman graduated from Carol Davila University of Medicine and Pharmacy in 1995.

Dr. Aloman is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.